Introduction
============

Annually, an estimated 63000 new cases of primary nonmalignant and malignant central nervous system (CNS) tumors are diagnosed in the United States with an estimated 13000 deaths. Most of the primary CNS tumors are located within the frontal, temporal, parietal and occipital lobes of the brain \[[@b1-IJCP-08-047]\]. There appear to be some difference between the patterns of brain tumor epidemiology in Iran and western countries. In the first report from Iran by Ameli et al. \[[@b2-IJCP-08-047]\], the prevalence of glioma was estimated to be about 45% of all brain tumors, somewhat low in comparison to the western reports, but almost the same as Southeast Asian countries. In fact, in Iranian reports of glial tumor subtypes, the majority of lesions are low grade astrocytoma and ependymomas \[[@b2-IJCP-08-047], [@b3-IJCP-08-047]\] which is very different from western countries, such as the US and France \[[@b4-IJCP-08-047]\].

Radiotherapy plays an important role in the management of most malignant and many benign primary CNS tumors. With the goal of achieving uncomplicated loco-regional tumor control, balancing between benefits and side effects is the art of radiation oncology \[[@b1-IJCP-08-047], [@b5-IJCP-08-047]-[@b10-IJCP-08-047]\]. The most important challenge in radiotherapy is delivering prescribed dose to the tumor and minimize dose to the normal tissues. Emami et al. obtained tolerance radiation dose of 28 critical organs; their findings showed the TD5/5 for lens, optic nerve, retina, chiasma, parotid and thyroid as 10, 50, 45, 50, 32 and 45 gray (Gy), respectively \[[@b11-IJCP-08-047]\]. An absorbed dose of 4 Gy to the lens of eye in three weeks to three months leads to cataract \[[@b12-IJCP-08-047]\]. So in the frontal lobe irradiation, lenses will not save at all and cataract will be induced. In other organs, although organ dose is tolerated, but in order to minimize complications it seems necessary to develop new technique. Two major complications might occur after frontal lobe irradiation; necrosis and visual disturbances which might be due to high dose received by chiasma \[[@b13-IJCP-08-047]-[@b15-IJCP-08-047]\].

In this study, for frontal lobe brain tumors three routine conventional radiotherapy techniques were compared in terms of dose distribution and absorbed dose to critical organs using treatment planning system (TPS) calculation and direct measurement in an anthropomorphic phantom. Then a new treatment technique was designed with same criteria as a mentioned above. Due to the high probability of visual disturbances in frontal lobe brain radiotherapy, we tried to reduce absorbed dose to the chiasma significantly considering new fields and bringing out the chiasma from radiation field with overall lower dose to other considered critical organs.

Materials and Methods
=====================

**Construction of phantom**

To construct the phantom, natural bone with Paraffin wax with Sodium Chloride (NaCl) as impurity was used; the effective atomic number and electron density of phantom soft tissue were 6.57 and 3.36×1023 (electron g-1), respectively. A hollow cavity and two hollow tubes were considered as the mouse cavity, trachea and esophagus, respectively. Six cylinders were made from phantom material which had cavities to insert Thermoluminescent Dosimeters (TLDs) at several depths, one for parotid (a transverse one from the left to the right parotid), one for Chiasma (perpendicularly inserted from top of brain), two for eyes and two for thyroids \[[@b16-IJCP-08-047]\] ([Figure 1](#f1-IJCP-08-047){ref-type="fig"}).

**TLD measurement technique**

Radiation dosimetry was done using cubic lithium fluoride TLD chips (3mm×3mm×1mm). The TLDs (TLD-100, Harshaw, USA) were initially sorted into groups of equal sensitivity. This was accomplished by delivering a known dose (100 cGy) from 6 MV X-ray (Siemens Primus linac) and consequently measurement of the output light from each TLD using a TLD reader (Harshaw model 3500 TLD reader, USA). The annealing cycle of TLDs consisted a heat cycle of 1 hour at 400ºC and then immediately 2 h at 100ºc. Calibration procedure was done by exposing TLD to 6MV photons in the range of 0-250 centigray (cGy). In order to measure dose values, a calibration curve was plotted in which the TLD reading in µc is related to absorbed dose in cGy. Besides, the linear calibration equation which used for dose measurement was fitted on experimental data points ([Figure 2](#f2-IJCP-08-047){ref-type="fig"}) \[[@b16-IJCP-08-047]-[@b19-IJCP-08-047]\].

**TPS and direct measurement on the phantom**

An imaginary 4 cm putative tumor with 2 cm margin was considered in the right frontal lobe of the brain and phantom was CT planned. Three routine conventional techniques associated with frontal lobe brain tumors were considered as two lateral opposite-fields (technique 1), one lateral and an anterior field (technique 2), two lateral opposite-fields and an anterior field (technique 3) \[[@b20-IJCP-08-047]\]. A new conventional technique with the benefits of conventional techniques and significantly reduced dose to chiasma was designed. This technique consists two 6 MV and 18 MV angled AP/PA fields with an oblique field with 18 MV photon beam. In angled AP/PA fields, the chiasma was brought out from radiation field with a couch rotation of 90º and gantry rotation of 10º; plan of the new technique and chiasma are brought in [figure 3](#f3-IJCP-08-047){ref-type="fig"}. The phantom was planned using above techniques (Prowess Panther treatment planning software, California, USA) with a total prescribed dose of 6000 cGy in 30 fractions. After contouring PTV and considered critical organs, dose distribution was obtained and absorbed dose to critical organs was extracted from the Dose Volume Histograms (DVH). As the dose fall-off was severe in organs closer to PTV, the selected points on plan (ROI) were about the same points where TLDs were placed in the phantom. TLDs were inserted in considered places in the phantom (retina, optic nerve, chiasma, lens, submandibular glands, parotids and thyroid) and the phantom was irradiated with above techniques.

Results
=======

The results of total absorbed dose to selected organs in selected points estimated from TPS and TLD in 30 fractions is presented in [figure 4](#f4-IJCP-08-047){ref-type="fig"} and [table 1](#t1-IJCP-08-047){ref-type="table"}.

In the assessed techniques, absorbed dose to all organs except lenses were at their tolerance dose levels and in the new technique, absorbed dose to chiasma is significantly reduced. Among all techniques, technique 2 (one lateral and an anterior field) was the best in terms of dose distribution, because of its localized irradiated volume at the side of brain.

The differences between calculation and measurement in selected techniques are presented in [table 2](#t2-IJCP-08-047){ref-type="table"} as percentage difference. As it is obvious, the differences were as high as 70% in organs far enough from considered PTV such as thyroid and submandibular glands, although absorbed doses were not comparable with their tolerance dose. Also in the new technique, differences were in the range of three routine techniques.

Discussion
==========

In clinical radiation therapy, usually TPS is used to estimate dose to different organs; but the obtained values might be different from the actual values depending on the clinical circumstances. Our findings showed differences in the range of 1-5% in all techniques between TPS and direct measurements for all organs except salivary glands and thyroid; although their distance from primary radiation field causes TLD reading being small, but differs with TPS (about 60%) which showed very smaller doses; this might be due to scattered radiation which is not well considered in the TPS. It has been showed that an increase in parotid irradiated volume from 0% -40% to 90% -100% (carried out in patients who had received a dose of 35-45Gy), results in decreased secretion from100% to 10% \[[@b21-IJCP-08-047]\].

Due to high probability of cataract induction in lens exposed to 400 cGy in three weeks to three months, and underestimation of doses obtained from plan and measurement at about 5% (\~20 cGy), it is important during planning to consider these differences to reduce the incidence of cataract.

As showed in [table 1](#t1-IJCP-08-047){ref-type="table"}, in three routine techniques, chiasma receives high doses (1800 -3000 cGy). As previously has reported \[[@b13-IJCP-08-047], [@b15-IJCP-08-047]\], Gensheimer et al. in a review on the outcomes of lacrimal gland adenoid cystic carcinoma treated with neutrons observed severe visual impairment which might be due to high dose to chiasma. Rischin et al. in studying with Sino-nasal undifferentiated carcinoma treated using three fields (weighted anterior field and two wedged laterals) found that mean dose to the optic chiasm was 54 Gy which exceeded from tolerance dose level \[[@b15-IJCP-08-047]\]; these high doses are in accordance with our study. So, as showed in [table 1](#t1-IJCP-08-047){ref-type="table"}, in the new technique we could reduce dose to chiasma as low as 596 cGy, and also save other organs better.

It is notable that in presented technique, although sparing other organ at risks, the absorbed dose to chiasma was measured as 596 cGy which showed a considerable dose reduction. This reduction might results in a less complication rate in radiotherapy of brain tumors.

Conclusion
----------

The present study sought estimates of the radiation doses received by organs at risk in the frontal lobe radiotherapy with direct measurement on the anthropomorphic phantom using TLD dosimetry. In addition, a comparison between the estimated values from treatment planning system and direct measurement shows differences in the range of 1.1% to 70% between the estimated and measured values. The dose values of some organs despite the large difference between the two methods, was within their tolerance dose and so there will be no concern about elevated risk of radiation induced adverse effects.
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![A) New technique consist of angled AP/PA and oblique fields, B) Bringing out the Chiasma.](IJCP-08-047f3){#f3-IJCP-08-047}

![A) Constructed head and neck phantom with TLD applicator; B) beam's eye view (BEV).](IJCP-08-047f1){#f1-IJCP-08-047}

![Absorbed dose to selected organs estimated from TPS and measured using TLDs in all technique: two lateral opposite-field (technique 1), one lateral and an anterior (technique 2), two lateral opposite-fields and an anterior (technique 3), angled AP/PA and oblique (new technique).](IJCP-08-047f4){#f4-IJCP-08-047}

###### 

Total absorbed dose to selected organs estimated from TPS and measured with TLDs in all technique in 30 fractions.

  Organ name              Technique 1   Technique2   Technique 3   NewTechnique   TD5/5                             
  ----------------------- ------------- ------------ ------------- -------------- -------- -------- ------- ------- ------
  **Left lens**           838.5         875.2        373.1         393            492      516.8    410.9   423.6   1000
  **Right lens**          502.7         512.8        722.3         741            458.1    466.9    763.1   781.9   1000
  **Left optic nerve**    1444.7        1503.3       807.1         816            826.7    862.9    274     278.2   5000
  **Right optic nerve**   1261.2        1298.8       939.4         957.5          869      897.7    363.1   377.1   5000
  **Left retina**         786.8         823.8        429           451.5          505.4    530.8    212     220.8   4500
  **Right retina**        693.1         701.5        623.7         626.2          551.3    556.8    333.6   345.7   4500
  **Left parotid**        23.3          35.8         20            50             32.8     46.85    15.1    30.2    3200
  **Right parotid**       17.8          22.25        30            42.9           53.7     55.36    25.2    31.5    3200
  **Chiasma**             1762.1        1783.5       3151          3205           2518.9   2544.3   585.9   596.6   5000
  **Thyroid**             7.9           15.8         5             16.6           6.3      19.68    1.5     4.1     4500
  **Submandibular**       12            23.1         10            23.8           16.2     33.1     2.2     4.7     3200

###### 

Percentage difference between measurement and TPS calculation in selected organs in all techniques

  Organ                   Technique 1   Technique 2   Technique 3   New Technique
  ----------------------- ------------- ------------- ------------- ---------------
  **Left lens**           4.2%          5%            4.8%          3%
  **Right lens**          2.1%          2.5%          1.9%          2.4%
  **Left optic nerve**    3.9%          1.1%          4.2%          1.5%
  **Right optic nerve**   2.9%          1.9%          3.2%          3.7%
  **Left retina**         4.5%          5%            4.8%          4%
  **Right retina**        1.2%          0.4%          1%            3.5%
  **Left parotid**        35%           60%           30%           50%
  **Right parotid**       20%           30%           3%            20%
  **chiasma**             1.2%          1.7%          1%            1.8%
  **thyroid**             50%           70%           68%           63%
  **submandibular**       48%           58%           51%           53%
